MedPath
TGA Approval

Cellular Therapies - T Cells - Tisagenlecleucel, cryopreserved - T - Kymriah - Novartis Pharmaceuticals Australia Pty Ltd - Suspension - Bag (475975)

475975

Cellular Therapies - T Cells - Tisagenlecleucel, cryopreserved - T - Kymriah - Novartis Pharmaceuticals Australia Pty Ltd - Suspension - Bag

Novartis Pharmaceuticals Australia Pty Ltd

January 16, 2025

Biological

Biological

Active

Included

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/c5ff9c88d31744a64967fab956ce2c10.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/8644b7b92362491f79d24dda6e8358fb.pdf

Active Ingredients

tisagenlecleucel

© Copyright 2025. All Rights Reserved by MedPath